Transcriptome Profiling of Circulating Tumor Cells to Predict Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer.
Autorzy:
GroenL; Department of Urology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands. Kloots I; Department of Medical Oncology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands. Englert D; ANGLE Biosciences Inc., Toronto, ON M9W 1B3, Canada. Seto K; ANGLE Biosciences Inc., Toronto, ON M9W 1B3, Canada. Estafanos L; ANGLE Biosciences Inc., Toronto, ON M9W 1B3, Canada. Smith P; ANGLE Biosciences Inc., Toronto, ON M9W 1B3, Canada. Verhaegh GW; Department of Urology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands. Mehra N; Department of Medical Oncology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands. Schalken JA; Department of Urology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
The Androgen Regulated lncRNA NAALADL2-AS2 Promotes Tumor Cell Survival in Prostate Cancer.
Autorzy:
GroenL; Department of Urology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. Yurevych V; Department of Urology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. Ramu H; Department of Urology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. Chen J; Department of Urology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. Steenge L; Department of Urology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. Boer S; Department of Genetics, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. Kuiper R; Department of Genetics, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. Smit FP; MDxHealth B.V., 6534 AT Nijmegen, The Netherlands. Verhaegh GW; Department of Urology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. Mehra N; Department of Medical Oncology, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. Schalken JA; Department of Urology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands.
Pokaż więcej
Źródło:
Non-coding RNA [Noncoding RNA] 2022 Dec 01; Vol. 8 (6). Date of Electronic Publication: 2022 Dec 01.
RNA Biomarkers as a Response Measure for Survival in Patients with Metastatic Castration-Resistant Prostate Cancer.
Autorzy:
Boerrigter E; Radboud University Medical Center, Department of Pharmacy, Radboud Institute for Health Sciences, 6525 GA Nijmegen, The Netherlands. Benoist GE; Radboud University Medical Center, Department of Pharmacy, Radboud Institute for Health Sciences, 6525 GA Nijmegen, The Netherlands. van Oort IM; Radboud University Medical Center, Department of Urology, Radboud Institute for Molecular Life Sciences, 6525 GA Nijmegen, The Netherlands. Verhaegh GW; Radboud University Medical Center, Department of Urology, Radboud Institute for Molecular Life Sciences, 6525 GA Nijmegen, The Netherlands. de Haan AFJ; Radboud University Medical Center, Department for Health Evidence, Biostatistics, 6525 GA Nijmegen, The Netherlands. van Hooij O; Radboud University Medical Center, Department of Urology, Radboud Institute for Molecular Life Sciences, 6525 GA Nijmegen, The Netherlands. GroenL; Radboud University Medical Center, Department of Urology, Radboud Institute for Molecular Life Sciences, 6525 GA Nijmegen, The Netherlands. Smit F; MDxHealth, 6534 AT Nijmegen, The Netherlands. Oving IM; Department of Medical Oncology, Ziekenhuisgroep Twente, 7609 PP Almelo, The Netherlands. de Mol P; Department of Medical Oncology, Gelderse Vallei Hospital, 6716 RP Ede, The Netherlands. Smilde TJ; Department of Medical Oncology, Jeroen Bosch Hospital, 5223 GZ 's-Hertogenbosch, The Netherlands. Somford DM; Department of Urology, Canisius Wilhelmina Hospital, 6532 SZ Nijmegen, The Netherlands. Hamberg P; Department of Medical Oncology, Franciscus Gasthuis & Vlietland, 3045 PM Rotterdam, The Netherlands. Dezentjé VO; Department of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, The Netherlands. Mehra N; Radboud University Medical Center, Department of Medical Oncology, 6525 GA Nijmegen, The Netherlands. van Erp NP; Radboud University Medical Center, Department of Pharmacy, Radboud Institute for Health Sciences, 6525 GA Nijmegen, The Netherlands. Schalken JA; Radboud University Medical Center, Department of Urology, Radboud Institute for Molecular Life Sciences, 6525 GA Nijmegen, The Netherlands.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Dec 14; Vol. 13 (24). Date of Electronic Publication: 2021 Dec 14.
Safety and Health Management System, Safety Climate, and Accident Occurrences in Hospitals: The Study of Needlestick, Sharp Injuries and Recidivism Rates.
The Associations of Affection and Rejection During Adolescence with Interpersonal Functioning in Young Adulthood: A Macro- and Micro- Level Investigation Using the TRAILS TRANS-ID Study
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
